Health
Women in 40s, 50s who survive COVID more likely to suffer persistent problems – Yahoo Finance Australia
Women in their 40s and 50s appear more at risk of long-term problems following discharge from hospital after being diagnosed with COVID-19. Many suffer…
2020 marked a year of successful evolution to a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients — Advancing selective chemoprotection via p53 biomarker strategy; 50% of all cancer patients across multiple tumor types have a p53 mutation Achieved clinical proof-of-concept in Phase 1b study of ALRN-6924 in p53-mutated small cell lung cancer (SCLC)Ailerons strategy is to ultimately pursue a tumor-agnostic indication — On track…
Continue Reading
